| Lisa F Mcdaniel, PD | |
|
11003 Hull Street Rd, Midlothian, VA 23112-3201 | |
| (804) 674-5291 | |
| Not Available |
| Full Name | Lisa F Mcdaniel |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 11003 Hull Street Rd, Midlothian, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063734655 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 0202007308 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lisa F Mcdaniel, PD 11003 Hull Street Rd, Midlothian, VA 23112 Ph: (804) 674-5291 | Lisa F Mcdaniel, PD 11003 Hull Street Rd, Midlothian, VA 23112-3201 Ph: (804) 674-5291 |
News Archive
In mammals, including humans, the heart muscle has a very limited capacity to recover after injury. After an acute myocardial infarction, millions of cardiac muscle cells, named cardiomyocytes, die, and are replaced by a scar.
Tumors can be damaging to surrounding blood vessels and tissues even if they're benign. If they're malignant, they're aggressive and sneaky, and often irrevocably damaging. In the latter case, early detection is key to treatment and recovery.
Researchers at UBC's Okanagan campus have developed a new and improved method to judge the effectiveness of experimental therapies for neurodegeneration-the progressive loss of neurons.
Targeted therapies have revolutionised the treatment of cancer since they were first introduced. Amongst the first medications approved in Europe, was the breast cancer drug Herceptin, which was approved in 2000. Then, the drug Glivec, was initially introduced to treat a certain form of leukaemia, and approved in 2001. Targeted therapies specifically inhibit molecules within so-called signalling pathways that usually control cell growth, death and differentiation. If they are altered, for example falsely inactivated or activated, the cells may start growing in an uncontrolled manner.
Severely ill patients with advanced heart failure who received a novel heart pump—the HeartMate 3 left ventricular assist device— suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
› Verified 4 days ago
Dr. Jeffrey Brochetti, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 112 Browns Way Rd, Midlothian, VA 23114 Phone: 804-305-3315 | |
Mrs. Amanda Toler Proost, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13700 Hull Street Rd, Midlothian, VA 23112 Phone: 804-739-9862 Fax: 804-739-8627 | |
Dr. Amy Cuenin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11119 Hull Street Rd, Midlothian, VA 23112 Phone: 804-744-5986 | |
Robert Richard Krzyzanowski, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11119 Hull Street Rd, Midlothian, VA 23112 Phone: 804-744-5986 | |
Mrs. Nawras M Abuyaman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11119 Hull Street Rd, Midlothian, VA 23112 Phone: 804-744-5986 | |
Hillary Anne Highman, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13201 Rittenhouse Dr, Pharmacy, Midlothian, VA 23112 Phone: 419-345-8385 |